Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Eli Lilly
LLY
$100K-$250K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–25 of 25
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Johnson & Johnson
JNJ
$50K-$100K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Gilead Sciences
GILD
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Alnylam Pharmaceuticals
ALNY
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Common Stock
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Vertex Pharmaceuticals
VRTX
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
-
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Common Stock
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Zoetis
ZTS
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Amgen
AMGN
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 1.1y ago· May 8, 2025
21 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Zoetis
ZTS
$15K-$50K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 8, 2025
21 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Merck
MRK
$15K-$50K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Stock
Filed 1.1y ago· May 8, 2025
21 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
AbbVie
ABBV
$50K-$100K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 8, 2025
27 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Amgen
AMGN
$15K-$50K
+7.1% vs S&P 500
Trade dateApr 11, 2025
Filed 1.1y ago· May 8, 2025
31 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Pfizer
PFE
$15K-$30K
+6.8% vs S&P 500
Trade dateApr 7, 2025
Pfizer, Inc.
Filed 1.1y ago· May 8, 2025
31 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Zoetis
ZTS
$15K-$50K
−59.3% vs S&P 500
Trade dateApr 7, 2025
Filed 1.1y ago· May 8, 2025
31 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Regeneron Pharmaceuticals
REGN
$15K-$50K
+10.4% vs S&P 500
Trade dateApr 7, 2025
Common Stock
Filed 1.1y ago· May 8, 2025
31 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Repligen
RGEN
$15K-$50K
+10.4% vs S&P 500
Trade dateApr 7, 2025
Stock
Filed 1.1y ago· Apr 11, 2025
11 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Gilead Sciences
GILD
$15K-$50K
+18.9% vs S&P 500
Trade dateMar 31, 2025
Filed 1.1y ago· Apr 11, 2025
29 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Vertex Pharmaceuticals
VRTX
$15K-$50K
−19.4% vs S&P 500
Trade dateMar 13, 2025
-
Filed 1.1y ago· Apr 11, 2025
37 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Zoetis
ZTS
$15K-$50K
−53.5% vs S&P 500
Trade dateMar 5, 2025
Filed 1.1y ago· Apr 11, 2025
37 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+40.9% vs S&P 500
Trade dateMar 5, 2025
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Merck
MRK
$15K-$50K
+23.8% vs S&P 500
Trade dateFeb 24, 2025
Stock
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Vertex Pharmaceuticals
VRTX
$15K-$50K
−13.1% vs S&P 500
Trade dateFeb 24, 2025
-
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+40.7% vs S&P 500
Trade dateFeb 24, 2025
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
AbbVie
ABBV
$50K-$100K
+6.5% vs S&P 500
Trade dateFeb 24, 2025
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Amgen
AMGN
$15K-$50K
+6.2% vs S&P 500
Trade dateFeb 24, 2025
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Eli Lilly LLY | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $100K-$250K midpoint $175K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Johnson & Johnson JNJ | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $50K-$100K midpoint $75K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Gilead Sciences GILD | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Alnylam Pharmaceuticals ALNY Common Stock | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Vertex Pharmaceuticals VRTX - | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Bristol-Myers Squibb BMY Common Stock | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Zoetis ZTS | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Amgen AMGN | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Zoetis ZTS | Apr 17, 2025 21 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Merck MRK Stock | Apr 17, 2025 21 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | AbbVie ABBV | Apr 17, 2025 21 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $50K-$100K midpoint $75K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Amgen AMGN | Apr 11, 2025 27 days to disclose | Good buy·+$5.1K+15.6% +7.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Pfizer PFE Pfizer, Inc. | Apr 7, 2025 31 days to disclose | Good buy·+$3.9K+17.2% +6.8% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Zoetis ZTS | Apr 7, 2025 31 days to disclose | Bad buy·−$15.9K-48.8% −59.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Apr 7, 2025 31 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Repligen RGEN Stock | Apr 7, 2025 31 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Gilead Sciences GILD | Mar 31, 2025 11 days to disclose | Good buy·+$6.7K+20.6% +18.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Mar 13, 2025 29 days to disclose | Bad buy·−$5.3K-16.2% −19.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Zoetis ZTS | Mar 5, 2025 37 days to disclose | Bad buy·−$17.6K-54.3% −53.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Johnson & Johnson JNJ | Mar 5, 2025 37 days to disclose | Good buy·+$13K+40.1% +40.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Merck MRK Stock | Feb 24, 2025 13 days to disclose | Good buy·+$7.9K+24.4% +23.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Feb 24, 2025 13 days to disclose | Bad buy·−$4.1K-12.5% −13.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Johnson & Johnson JNJ | Feb 24, 2025 13 days to disclose | Good buy·+$13.4K+41.3% +40.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | AbbVie ABBV | Feb 24, 2025 13 days to disclose | Good buy·+$5.4K+7.1% +6.5% vs S&P 500 | $50K-$100K midpoint $75K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Amgen AMGN | Feb 24, 2025 13 days to disclose | Good buy·+$2.2K+6.8% +6.2% vs S&P 500 | $15K-$50K midpoint $32.5K |